Ignite Creation Date:
2025-12-24 @ 3:59 PM
Ignite Modification Date:
2026-06-20 @ 6:20 AM
Study NCT ID:
NCT04348292
Status:
TERMINATED
Last Update Posted:
2024-08-22
First Post:
2020-02-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Sirolimus and Durvalumab for the Treatment of Stage I-IIIA Non-small Cell Lung Cancer
Sponsor:
Emory University
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Lung Non-Small Cell Carcinoma | View |
| None | Stage I Lung Cancer AJCC v8 | View |
| None | Stage IA1 Lung Cancer AJCC v8 | View |
| None | Stage IA2 Lung Cancer AJCC v8 | View |
| None | Stage IA3 Lung Cancer AJCC v8 | View |
| None | Stage IB Lung Cancer AJCC v8 | View |
| None | Stage II Lung Cancer AJCC v8 | View |
| None | Stage IIA Lung Cancer AJCC v8 | View |
| None | Stage IIB Lung Cancer AJCC v8 | View |
| None | Stage IIIA Lung Cancer AJCC v8 | View |
Keywords: